Dow Inc vs Nomura Holdings Inc — how do they compare? Dow Inc trades at $28.42 (market cap $20.65B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Nomura Holdings Inc is the larger of the two by market cap, and Dow Inc pays the higher dividend (4.9%). Which is the better fit depends on your goals — on Pluang, investors hold Dow Inc for 82 Days and Nomura Holdings Inc for 55 Days on average.
| DOW | NMR | |
|---|---|---|
Market Cap | $20.65B | $27.55B |
Volume | 14,126,943 | 782,470 |
Sector | Basic Materials | Financials |
52-Week High | $41.87 | $10.86 |
52-Week Low | $20.65 | $6.73 |
Typical Hold Time | 82 Days | 55 Days |
Enterprise Value | $36.34B | $38.54T |
Dividend Yield | 4.9% | 3.4% |
Signals from Pluang's Aura AI — not financial advice
DOW trades at $28.59, up 2.95% today, near the analyst low target of $28.00. The stock shows a bullish technical signal despite mixed indicators, with recent earnings beats in Q4 2025 through Q2 2026. However, fundamentals are weak, with a negative net income margin of -3.13% in 2025 and declining revenue from $56.9B in 2022 to $40.0B in 2025. Cash flow trends improved in 2025, but debt-to-asset ratios have risen to 29.87%.
The outlook is cautious; while analyst consensus is a buy with a $34.22 target, high valuation (P/E 75.93) and profitability challenges pose risks. Opportunities include dividend stability and potential margin recovery, but investors face headwinds from cyclical demand and competitive pressures in the chemicals sector.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →